Second, while mutational scar-based methods of detecting HRD identify HRD cases beyond BRCA1/2 mutations, a principal limitation of detecting mutational and genomic scars is that these represent past events and do not necessarily reflect current HRD status, possibly resulting in false-positive or false-negative classification of a tumor according to HRD status. Here, BRCA1 is linked to neoplasm.